Human Milk Oligosaccharides Market Outlook 2025–2035: Global Trends
The human milk oligosaccharides (HMO) market is moving into a transformative phase, poised to grow from USD 101.1 million in 2025 to USD 191.6 million by 2035, at a steady CAGR of 6.6%. Long recognized for their critical role in infant development, HMOs are now crossing into new categories, including functional foods, nutraceuticals, and clinical nutrition. Industry leaders and new entrants alike are making strategic moves to expand capacity, accelerate innovation, and meet the surging demand for these bioengineered ingredients. Infant formula remains the primary driver, expected to account for 60% of the market in 2025. At the same time, functional food and dietary supplement applications are carving a growing share, as HMOs gain recognition for their prebiotic, immune-modulating, and gut-brain axis benefits. The Asia-Pacific region, led by China and India, is emerging as a growth hotspot, with Europe and North America maintaining their dominance through technological innovati...